News

Nearly three quarters of employees would leave their jobs for better family benefits.

The city of Baltimore, which paid more than $11 million in 2023 for diabetes medications through its self-funded plan, is suing the drug manufacturers, for allegedly conspiring to artificially hike the price of insulin.

On Tuesday, the justices will hear arguments on whether to revoke mifepristone's approval and curtail its availability because the FDA imposed strict safety limits on who could prescribe and distribute it when it gave its approval.

John Oxendine admitted to his role in a health care kickback scheme that netted him hundreds of thousands of dollars.

The proliferation of advertising on social media for Ozempic, Wegovy and other weight loss drugs will be a key part of the upcoming "stomach paralysis" lawsuits against Novo Nordisk and Eli Lilly.

The weeks-long outage at Change Healthcare, which was hit with a cyberattack, could negatively impact the credit of smaller providers and pharmacies that depend on it for financial services, warns the credit rating agency.